Background: Blood oxygen saturation (SpO 2 ) is frequently measured to determine acclimatization status in high-altitude travellers. However, little is known about nocturnal time course of SpO 2 (SpO 2N ), but alterations in SpO 2N might be practically relevant as well. To this end, we describe the time-course of SpO 2N in mountaineers at high altitude. Methods: SpO 2N was continuously measured in ten male mountaineers during a three-week expedition in Peru (3,050-6,354m). Average SpO 2N of the first (SpO 2N1 ) and second half (SpO 2N2 ) of an individual's sleep duration was calculated from 2h intervals of uninterrupted sleep. Heart rate oscillations and sleep dairies were used to exclude periods of wakefulness. SpO 2 was also measured at rest in the morning. Results: SpO 2N significantly increased from SpO 2N1 to SpO 2N2 . The magnitude of this increase (DSpO 2 ) was reduced with time spent at altitude. On night 1 (3,050m) SpO 2 increased from 83.4% (N1) to 86.3% (N2). At the same location on night 21, SpO 2 increased from 88.3% to 90.1%, which is a relative change of 4.7% and 2.0%, respectively. This pattern of increase in SpO 2N was perturbed when individual acclimatization was poor or altitude was extreme (5630m). SpO 2N was significantly lower than SpO 2 at rest in the morning. Conclusions: This study is the first to demonstrate an increase of SpO 2 during the night in mountaineers at high altitude (3,050-6,354m) with high consistency between and within subjects. The magnitude of DSpO 2N decreased as acclimatization improved, suggesting that these changes in DSpO 2 between nights might be a valuable indicator of individual acclimatization. In addition, the failure of any increase in SpO 2N during the night might indicate insufficient acclimatization. Even though underlying mechanisms for the nocturnal increase remain unclear, the timing of SpO 2N measurement is obviously of utmost importance for its interpretation. Finally our study illustrates the detailed effects of ventilatory acclimatization over several weeks.
Introduction
The number of tourists traveling to high altitude all over the world is estimated to reach 100 million 1 per year or more. 2 During these sojourns blood oxygen saturation (SpO 2 ) is frequently measured by pulse oximetry, aiming to assess individual acclimatization status. [3] [4] [5] Sometimes scientists, mountaineers, and expedition doctors are trying to predict the occurrence of acute mountain sickness (AMS) 3, 6 by SpO 2 measurements, which is still matter of controversial discussion. 7, 8 The interpretation of SpO 2 is based on absolute values and on their difference between normoxia and hypoxia. However, the level of SpO 2 not only depends on individual acclimatization status and exercise intensity, but also on diurnal variation. 9, 10 Therefore, knowledge on the time course of SpO 2 is necessary for any interpretation of SpO 2 changes. Variations over time in nocturnal SpO 2 (SpO 2N ) may be of particular interest, since the nocturnal period is normally stable and physically inactive. Original article morning or selectively at day-or night-time 4 while focusing on AMS, periodic breathing [11] [12] [13] or pharmaceutical interventions. 12 Notably, even though several of these studies measured SpO 2 continuously, little has been reported about the time course of SpO 2N . 14, 15 To this end, we measured SpO 2N in sleeping mountaineers during a 3-week expedition at high and extreme altitude (3050-6354 m) while paying particular attention on the magnitude of changes in SpO 2N in order to optimize interpretation of SpO 2 saturation profiles. Figure 1 . The mountaineers arrived in Lima, Peru (161 m) by plane and travelled directly to Huaraz (3050 m) by bus via a pass at 4100 m. They spent 3 days in Huaraz before leaving for the first summit.
Materials and Methods

Expedition and Participants
Time Points of Measurement
SpO 2N was measured on nights 1, 5, 9, and 19. On each of these nights, sleeping altitude was higher than on the preceding nights (Table 1 ). In addition, SpO 2N was measured on nights 2 and 3 to evaluate possible changes in SpO 2N time course during initial acclimatization to high altitude. Finally, SpO 2N was measured on night 21 to evaluate changes in acclimatization status in comparison to night 1, which was spent at the same location (Table 1, Figure 1 ). No participant had slept higher than 1500 m during the 2 weeks before the expedition. Night 0 was spent in the plane with a barometric pressure roughly corresponding to 2250 m.
Oxygen Saturation Measurements
SpO 2 and heart rate were recorded by pulse oximeters that logged data in 4s intervals (Nonin PalmSat 2500V R , validated for use down to -20 C and up to 12 000 m, saturation claimed accuracy is 70-100% and pulse rate declared accuracy is 40-240 bpm). To allow proper sensor placement beneath gloves, flat and flexible finger clips were used (NoninV R adult flex sensor). The wire of the sensors was 2.4 m long to allow for movements during sleep in the sleeping bag.
Average SpO 2N of the first (SpO 2N1 ) and second half (SpO 2N2 ) of an individual's sleep duration was calculated from 2h intervals of uninterrupted sleep. For valid retrospective detection and analysis of these sleep phases, every participant kept a sleep dairy where he recorded wake phases and special events (e.g. coughing, urination) during the night. These wake phases were excluded from the analysis. The second criterion for the selection of sleep phases was based on the analysis of individual SpO 2 and heart rate data, where we excluded apparent sleep phases with increases in average heart rate ! 10 bpm compared to the preceding interval. SpO 2 at rest (SpO 2rest ) was measured every morning for 2 min after waking up and before breakfast. SpO 2rest was not averaged.
Lake Louise Scores
The Lake Louise Scoring system (LLS) was used to score symptoms of acute mountain sickness. 16 Participants scored themselves every morning using the self-assessment part of the LLS. An experienced expedition doctor evaluated the LLS and identified non altitude-related symptoms.
Statistical Analysis
Data are expressed as median and range (minimum -maximum). To compare SpO 2 data between time points of measurement a paired t-test was used. A p-value of less than .05 was considered being statistically significant. Saturation data are described as absolute saturation values (SpO 2N1/N2/rest, expressed as %) and relative percentage change of SpO 2N overnight (DSpO 2N, expressed as r%). The latter was calculated using equation 1: Night 0 was spent in the airplane with a barometric pressure equal to 2250 m.
Results
All participants (P) completed the expedition. Data of P8 are missing on night 19 (5630 m), because P8 lost the pulse oximeter's finger clip. Furthermore, it was not possible to detect a continuous N2-sleeping period of 2 h-duration in P6 and P10 on night 19 . This was probably due to the early wake up time for the summit ascent at 2:00 AM.
Group Analysis
SpO 2N1 was significantly lower than SpO 2N2 (P 0.001) on nights 1, 5, and 9 ( Figure 2 ). On night 19 (5630 m) SpO 2N1 was lower than SpO 2N2 in four participants but higher than in the other three participants (Figure 4 ). These changes were not significant. SpO 2rest was consistently higher than SpO 2N1 (P 0.001) and SpO 2N2 (P 0.001) in the mornings after nights 1, 5 and 9 ( Figure 2 ). 
Impact of Acclimatization on
Impact of Acclimatization on the Nocturnal Increase of SpO 2
SpO 2N2 was significantly higher than SpO 2N1 (P 0.001) on nights 1, 2, 3, and 21 at 3050 m. However, the magnitude decreased from 3.6% (-0.7 -9.6) on night 1, to 2.2% (0.6 -4.9) on night 2, to 1.9% (0.7 -4.3) on night 3, and finally to 1.8% (0.8 -2.1) on night 21 ( Figure 3 ). Accordingly the relative percentage decrease was: DSpO 2N on night 1: 4.7 r% (-0.8 -12.4), night 2: 2.5 r% (0.7 -5.9), night 3: 2.4 r% (0.8 -5.1) and night 21:2.0 r% (0.9 -2.4).
Single Case Description
During the first three nights spent at 3050 m in Huaraz (nights 1, 2, and 3), SpO 2N in P7 did not increase to the same extent as in the rest of the group: During night 1, P7's SpO 2N decreased from 86.0% (N1) to 85.3% (N2), corresponding to DSpO 2N -0.8 r%. In the other participants SpO 2N significantly increased from 83.2% (78.7 -84.4) (N1) to 86.5% (84. 4 À 88.2%) (N2), corresponding to DSpO 2N 5.3 r% (Figure 3 (Figure 4) .
Notably, P7 suffered from AMS more than any other participant during first part of the expedition. Average LLS of the first six mornings amounted to 6.0 a.u. in P7, but 2.3 a.u. (0.0 -4.1) in the rest of the group. LLS peaked at 10 a.u. in P7 after night 6 at 4330 m while amounting to 2.9 a.u. (0 -5) in the rest of the group. P7 was treated with Acetazolamide bid 250 mg for 3 days (day 5-7) and Ibuprofen tid 600 mg for 6 days after reaching the base camp (day 5-10). From day 1 to day 15, P7 was not able to climb higher than 4825 m and was therefore excluded from the analysis of night 9. P7's sleeping altitude never exceeded 4330 m 
Discussion
Important initial studies concerning breathing patterns at altitude were undertaken early in the 19th century. 17 Despite several studies measuring nocturnal SpO 2 at altitude 18, 19 which focus on periodic breathing, sleep disturbances, or AMS, [11] [12] [13] 20, 21 we are -to the best of our knowledge -the first to report a significant increase of SpO 2N between the first and second half of individual sleep duration in mountaineers at altitude (3050 -6354 m) with a decreasing magnitude of this nocturnal increase as acclimatization improves. Our detailed data on increasing SpO 2N are in line with the limited available findings: Normand et al. measured SpO 2 continuously in 6 persons living at 3800 m for 3 weeks and reported decreasing SpO 2 during sleep in comparison to the waking state and a sudden rise in SpO 2 just before awaking. In that study, SpO 2 was measured continuously and averaged over 5min, but the SpO 2 -time course was not reported, since the study primarily focused on events of periodic breathing. 14 Bernardi et al. reported a circadian rhythm of SpO 2 reaching a nadir between 2:00 AM and 3:00 AM, but no numeric data or detailed figures were reported. 10 Studies reporting a decrease of diurnal SpO 2 would support our results since an increase of SpO 2 during the night becomes inevitable if SpO 2 decreases during the day to avoid a summative reduction. Our group has already measured a decreasing SpO 2 during the day in 15 resting mountaineers at 3371 m in the central European area of Mount Blanc, 9 where SpO 2rest decreased from 92% (88 -96) at 7:00 AM to 88% (83 -92) at 8:30 PM down to 85% (74 -89) at 12.00 PM. We surmise that the nocturnal increase of SpO 2 is in line with this finding, as well as our observation to find the highest SpO 2 values at rest in the morning as reported by Wickramasinghe et al.
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, there are little data available on time course variations of SpO 2.
Underlying Mechanisms
Undoubtedly, ventilatory acclimatization is the main reason for any long-and mid-term changes in SpO 2 . The impact of acclimatization becomes obvious in the SpO 2 -increase (SpO 2N1 , SpO 2N2 , SpO 2rest ) after 3 weeks spent at altitude (i.e. night 1 vs night 21 in Huaraz), which is the result of acclimatization. 3, 21, 23 The time course of SpO 2N deserves further attention and possible mechanisms will be discussed briefly.
Periodic Breathing
Nocturnal periodic breathing is a typical response to hypoxia 14, 19, 24, 25 and has traditionally been understood as a maladaptation that contributes to the altitude related hypoxemia and the magnitude of pCO 2 -reduction. 11 However, recent research has deemed it beneficial in hypoxia. 11, 24 Periodic breathing induces changes of SpO 2 , albeit its impact on mean SpO 2 is negligible and cannot explain the nocturnal variation in SpO 2 observed in our study.
Circadian Rhythm
On a descriptive level, the SpO 2N alterations show a circadian profile. 26 Cortisol is a hormone secreted in a circadian rhythm, which affects respiration by shifting the CO 2 -breathing curve 27 due to the augmented stimulatory or permissive effect of catecholamines. 28 3, 31 This effect also became obvious in our study (Figure 3 ), but notably DSpO 2N decreased during the expedition, indicating that this change might be a valuable variable to estimate the individual degree of acclimatization. We cannot compare this new finding to the literature, since it has not been reported before, but our results consistently point to the concept, that the nocturnal increase is a surrogate marker of acclimatization, which is furthermore supported by the following in-depth analysis.
Single Case Analysis and DSpO 2N at Extreme Altitude
Data of P7 strongly support the idea of using DSpO 2N as a marker of individual acclimatization: The failure to increase SpO 2N on night 1 ( Figure 3 ) indicated an insufficient acclimatization in P7. He was the only one throughout the entire expedition showing a negative DSpO 2N on night 1 and DSpO 2N increased only slightly during the first part of the expedition. In addition, P7 suffered more from AMS than any other climber. However, after 18 days of acclimatization, he showed a 32 and SpO 2N did not increase in three mountaineers but remained unchanged or even decreased (Figure 4) , suggesting that DSpO 2N might be a valuable marker of individual acclimatization.
Limitations
The definition of undisturbed sleep phases was based on the participants' sleep dairy and on heart rate analysis. A small and lightweight sleep data recorder with movement sensors could improve the quality of these data. Moreover, our study is limited by the small sample size, which is a general problem of alpine field studies. 15 
Conclusion
This study is the first to demonstrate an increase of SpO 2 during the night in mountaineers at both high and extreme altitude (3050-6354 m) with high consistency between and within subjects. The magnitude of changes in SpO 2 during the night decreased as acclimatization improved, suggesting that these changes in DSpO 2 between nights might be a valuable indicator of individual acclimatization. In addition, the failure of any increase in SpO 2N during the night might indicate insufficient acclimatization. Even though underlying mechanisms for the nocturnal increase remain unclear, the timing of SpO 2N measurement is obviously of utmost importance for its interpretation. Finally, our study illustrates the detailed effects of ventilatory acclimatization over several weeks. 
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